Request Deal Involvement

Hillhouse Capital to invest £176m in Genscript Biotech-backed Probio Cayman.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Jones Day

legal advisors

Jones Day

or

Principals

GENSCRIPT BIOTECH

vendor

GENSCRIPT BIOTECH

HILLHOUSE CAPITAL GROUP

bidder

HILLHOUSE CAPITAL GROUP

PROBIO CAYMAN

target

PROBIO CAYMAN

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite